Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sommadossi

Showing results (81-90 of 175) with videos related to

Pageof 18
Sort By:
Journal of Immunoassay|May 1, 1996
Quantitation of 3'-amino-3'-deoxythymidine (AMT), a toxic catabolite of 3'-azido-3'-deoxythymidine (AZT), by competitive ELISAB Ferrua, H Chakboub, C Roptin, et al.
Bioorganic & Medicinal Chemistry|March 4, 2009
Synthesis and antiviral evaluation of thieno[3,4-d]pyrimidine C-nucleoside analogues of 2',3'-dideoxy- and 2',3'-dideoxy-2',3'-didehydro-adenosine and -inosineMarie Hamann, Claire Pierra, Jean-Pierre Sommadossi, et al.
Nucleosides & Nucleotides|August 5, 1999
Stereospecific synthesis and antiviral activities of beta-L-2',3'-dideoxy-5-chloropyrimidine nucleoside derivativesC Pierra, G Gosselin, J P Sommadossi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2001
Symptomatic lactic acidosis in hospitalized antiretroviral-treated patients with human immunodeficiency virus infection: a report of 12 casesM E Coghlan, J P Sommadossi, N C Jhala, et al.
Biochemical Pharmacology|September 1, 1992
Catabolic disposition of 3'-azido-2',3'-dideoxyuridine in hepatocytes with evidence of azido reduction being a general catabolic pathway of 3'-azido-2',3'-dideoxynucleosidesE M Cretton, M Y Xie, N M Goudgaon, et al.
Antiviral Research|March 1, 1996
Selective protection of toxicity of 2',3'-dideoxypyrimidine nucleoside analogs by beta-D-uridine in human granulocyte-macrophage progenitor cellsA Faraj, R F Schinazi, M Y Xie, et al.
Expert Opinion on Investigational Drugs|January 24, 2024
Bemnifosbuvir (BEM, AT-527), a novel nucleotide analogue inhibitor of the hepatitis C virus NS5B polymeraseXiao-Jian Zhou, Steven S Good, Keith Pietropaolo, et al.
Antiviral Research|May 23, 2001
Evaluation of the mutagenic and genotoxic activities of anti-hepatitis B analogs of beta-L-adenosine by the Ames test and the Comet assayL Placidi, M De Meo, G Gosselin, et al.
Cancer Research|January 1, 1985
Modulation of 5-fluorouracil catabolism in isolated rat hepatocytes with enhancement of 5-fluorouracil glucuronide formationJ P Sommadossi, D A Gewirtz, D S Cross, et al.
Antiviral Research|October 13, 2025
Mapping the impact of 1'-, 2'- and 4'-nucleotide modifications on the Respiratory Syncytial Virus RNA-dependent RNA polymerasePriscila Sutto-Ortiz, Barbara Selisko, François Ferron, et al.
Pageof 18

Showing results (81-90 of 175) with videos related to

Sort By:
Pageof 18
Journal of Immunoassay|May 1, 1996
Quantitation of 3'-amino-3'-deoxythymidine (AMT), a toxic catabolite of 3'-azido-3'-deoxythymidine (AZT), by competitive ELISAB Ferrua, H Chakboub, C Roptin, et al.
Bioorganic & Medicinal Chemistry|March 4, 2009
Synthesis and antiviral evaluation of thieno[3,4-d]pyrimidine C-nucleoside analogues of 2',3'-dideoxy- and 2',3'-dideoxy-2',3'-didehydro-adenosine and -inosineMarie Hamann, Claire Pierra, Jean-Pierre Sommadossi, et al.
Nucleosides & Nucleotides|August 5, 1999
Stereospecific synthesis and antiviral activities of beta-L-2',3'-dideoxy-5-chloropyrimidine nucleoside derivativesC Pierra, G Gosselin, J P Sommadossi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2001
Symptomatic lactic acidosis in hospitalized antiretroviral-treated patients with human immunodeficiency virus infection: a report of 12 casesM E Coghlan, J P Sommadossi, N C Jhala, et al.
Biochemical Pharmacology|September 1, 1992
Catabolic disposition of 3'-azido-2',3'-dideoxyuridine in hepatocytes with evidence of azido reduction being a general catabolic pathway of 3'-azido-2',3'-dideoxynucleosidesE M Cretton, M Y Xie, N M Goudgaon, et al.
Antiviral Research|March 1, 1996
Selective protection of toxicity of 2',3'-dideoxypyrimidine nucleoside analogs by beta-D-uridine in human granulocyte-macrophage progenitor cellsA Faraj, R F Schinazi, M Y Xie, et al.
Expert Opinion on Investigational Drugs|January 24, 2024
Bemnifosbuvir (BEM, AT-527), a novel nucleotide analogue inhibitor of the hepatitis C virus NS5B polymeraseXiao-Jian Zhou, Steven S Good, Keith Pietropaolo, et al.
Antiviral Research|May 23, 2001
Evaluation of the mutagenic and genotoxic activities of anti-hepatitis B analogs of beta-L-adenosine by the Ames test and the Comet assayL Placidi, M De Meo, G Gosselin, et al.
Cancer Research|January 1, 1985
Modulation of 5-fluorouracil catabolism in isolated rat hepatocytes with enhancement of 5-fluorouracil glucuronide formationJ P Sommadossi, D A Gewirtz, D S Cross, et al.
Antiviral Research|October 13, 2025
Mapping the impact of 1'-, 2'- and 4'-nucleotide modifications on the Respiratory Syncytial Virus RNA-dependent RNA polymerasePriscila Sutto-Ortiz, Barbara Selisko, François Ferron, et al.
Pageof 18